PDL BIOPHARMA, INC. as Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee SUPPLEMENTAL INDENTURE Dated as of May 16, 2011 3.75% Convertible Senior Notes due 2015Supplemental Indenture • May 16th, 2011 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
SUPPLEMENTAL INDENTURE, dated as of May 16, 2011, between PDL BioPharma, Inc., a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A, as trustee (the “Trustee”) under the Indenture dated as of May 16, 2011, between the Company and the Trustee (as amended or supplemented from time to time in accordance with the terms thereof, the “Original Indenture”).
PDL BIOPHARMA, INC. (a Delaware corporation) 3.75% Convertible Senior Notes Due 2015 UNDERWRITING AGREEMENT Dated: May 10, 2011Underwriting Agreement • May 16th, 2011 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
the restrictions imposed by this lock-up agreement shall continue to apply until the expiration of the 18-day period beginning on the issuance of the earnings release or the occurrence of the material news or material event, as applicable, unless Merrill Lynch waives, in writing, such extension.
